PBLA - Panbela Therapeutics GAAP EPS of -$7.95 misses by $3.24 August, 10 2023 04:21 PM Panbela Therapeutics Inc Com 2023-08-10 16:21:54 ET Panbela Therapeutics press release ( NASDAQ: PBLA ): Q2 GAAP EPS of -$7.95 misses by $3.24 . Total cash was $7.2 million as of June 30, 2023. For further details see: Panbela Therapeutics GAAP EPS of -$7.95 misses by $3.24